A multi-institutional phase II open-label study of AMG 479 in advanced carcinoid and pancreatic neuroendocrine tumors.
Matthew Kulke
Consultant or Advisory Role - Ipsen; Lexicon; Novartis; Pfizer
Research Funding - Novartis
Jennifer A. Chan
No relevant relationships to disclose
David P. Ryan
No relevant relationships to disclose
Jeffrey A. Meyerhardt
No relevant relationships to disclose
Charles S. Fuchs
No relevant relationships to disclose
Thomas Adam Abrams
No relevant relationships to disclose
Eileen Regan
No relevant relationships to disclose
Rachel Brady
No relevant relationships to disclose
Jill M. Weber
No relevant relationships to disclose
Tiffany Campos
No relevant relationships to disclose
Larry Kvols
Honoraria - Novartis
Jonathan R. Strosberg
Consultant or Advisory Role - Novartis
Honoraria - Genentech
Research Funding - Amgen; Novartis; Pfizer